Psychiatrienet - User contributions [en]

Stop-

2026-04-14T14:58:12Z

Joost: Created page with "*There is a low risk at withdrawal symptoms, therefore vortioxetine could be stopped abruptably."

*There is a low risk at withdrawal symptoms, therefore vortioxetine could be stopped abruptably.

Template:Drugswitch

2026-04-14T14:46:23Z

Joost:

{| align="right" class="mywrapper"
|-
{{#if:{{{from|}}}|{{!}}{{:{{{from}}} }} }}
|-
{{#if:{{{to|}}}|{{!}}{{:{{{to}}} }} }}
|}
{{#if:{{{from|}}}|{{#if:{{{to|}}}|Switch medication from '''{{{from}}}''' to '''{{{to}}}'''<ref>Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules</ref><ref>Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.</ref>}}
}}
{{#if:{{{header|}}}|{{ {{{header}}} }}|}}
{{#if:{{{stop|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:Nietinrijdenbord.png|18px]] Stop {{{from}}} </div>
{{{stop|}}}
}}
{{#if:{{{start|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:Eenrichtingbord.png|18px]] Start {{{to}}}</div>
{{{start|}}}
}}
{{#if:{{{caveat|}}}{{{cave|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:letopbord.png|18px]] Cave</div>
{{{caveat|}}}{{{cave|}}}
}}
{{#if:{{{info|}}}{{{view|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:Infobord.png|18px]] More information</div>
{{{info|}}}{{#if:{{{view|}}}|

<div class="mypicture">[[File:{{{view|}}}]]</div>
<div class="mylegend">{{#if:{{{from|}}}|<span style="color: red;">[[image:Nietinrijdenbord.png|10px]] — {{{from}}}</span><br />}}{{#if:{{{to|}}}|<span style="color: blue;">[[image:Eenrichtingbord.png|10px]] — {{{to}}}</span>}}</div>}}

}}<br clear="all"/>

{{#if:{{{footer|}}}|{{ {{{footer}}} }}|}}
<div class="myrefs"><references /></div>
<div class="disclaimer">{{:Project:General_disclaimer}}</div>
<includeonly>
__HIDDENCAT__ [[Category:Switch]]
{{#if:{{{from|}}}| __HIDDENCAT__ [[Category:Switch{{{from}}}]] }}
{{#if:{{{to|}}}| __HIDDENCAT__ [[Category:Switch{{{to}}}]] }}
</includeonly>

Template:Drugswitch

2026-04-14T14:37:43Z

Joost:

Template:Drugswitch

2026-04-14T14:36:56Z

Joost:

{| align="right" class="mywrapper"
|-
{{#if:{{{from|}}}|{{!}}{{:{{{from}}} }} }}
|-
{{#if:{{{to|}}}|{{!}}{{:{{{to}}} }} }}
|}
{{#if:{{{from|}}}|{{#if:{{{to|}}}|Switch medication from '''{{{from}}}''' to '''{{{to}}}'''<ref>Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules</ref><ref>Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.</ref>}}
}}
{{#if:{{{header|}}}|{{ {{{header}}} }}|}}
{{#if:{{{stop|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:Nietinrijdenbord.png|18px]] Stop {{{from}}} </div>
{{{stop|}}}
}}
{{#if:{{{start|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:Eenrichtingbord.png|18px]] Start {{{to}}}</div>
{{{start|}}}
}}
{{#if:{{{caveat|}}}{{{cave|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:letopbord.png|18px]] Cave</div>
{{{caveat|}}}{{{cave|}}}
}}
{{#if:{{{info|}}}{{{view|}}}|
<div style="font-size:20px; margin-top:20px;">[[image:Infobord.png|18px]] More information</div>
{{{info|}}}{{#if:{{{view|}}}|

<div class="mypicture">[[File:{{{view|}}}]]</div>
<div class="mylegend">{{#if:{{{from|}}}|<span style="color: red;">[[image:Nietinrijdenbord.png|10px]] — {{{from}}}</span><br />}}{{#if:{{{to|}}}|<span style="color: blue;">[[image:Eenrichtingbord.png|10px]] — {{{to}}}</span>}}</div>}}

{{#if:{{{rapid|}}}|
<div style="margin-top:20px;">

{| class="wikitable mw-collapsible mw-collapsed" style="width:700px;"
! Rapid switch
|-
|
{{{rapid}}}
|}

</div>
}}

}}<br clear="all"/>

{{#if:{{{footer|}}}|{{ {{{footer}}} }}|}}
<div class="myrefs"><references /></div>
<div class="disclaimer">{{:Project:General_disclaimer}}</div>
<includeonly>
__HIDDENCAT__ [[Category:Switch]]
{{#if:{{{from|}}}| __HIDDENCAT__ [[Category:Switch{{{from}}}]] }}
{{#if:{{{to|}}}| __HIDDENCAT__ [[Category:Switch{{{to}}}]] }}
</includeonly>

Template:Testtesttest

2026-04-14T14:36:13Z

Joost:

{{#if:{{{rapid|}}}|
<div style="margin-top:20px;">

{| class="wikitable mw-collapsible mw-collapsed" style="width:700px;"
! Rapid switch
|-
{{Drugswitch
| from = agomelatine
| to = amitriptyline
| stop = {{StopAgomelatine}}
| start =
{{Inc25p3d2}}
* Therapeutic Drug Monitoring of amitriptyline is useful, especially during the build up phase. Blood sampling is possible when reaching a steady state with the same dose after one week.

|info =
* A wash-out period is not necessary.
}}
|
{{{rapid}}}
|}

</div>
}}

Template:Testtesttest

2026-04-14T14:35:18Z

Joost:

{{#if:{{{rapid|}}}|
<div style="margin-top:20px;">

{| class="wikitable mw-collapsible mw-collapsed" style="width:700px;"
! Rapid switch
|-
|
{{{rapid}}}
|}

</div>
}}

Stop-fenelzine

2026-04-14T14:30:38Z

Joost: Created page with "*Decrease fenelzine with 15 mg every 2 weeks."

*Decrease fenelzine with 15 mg every 2 weeks.

Fenelzine-tranylcypromine

2026-04-14T14:30:14Z

Joost:

{{Drugswitch
| from = fenelzine
| to = tranylcypromine
| stop =
*Decrease fenelzine with 15 mg every 2 weeks.
{{14dWashout}}<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>

| start =
{{Starttranyl}}
| caveat =
{{caveSS}}
{{switchMAO}}

}}

Fenelzine-tranylcypromine

2026-04-14T14:29:02Z

Joost:

{{Drugswitch
| from = fenelzine
| to = tranylcypromine
| stop =
15 mg fenelzine per twee weken
{{14dWashout}}<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>

| start =
{{Starttranyl}}
| caveat =
{{caveSS}}
{{switchMAO}}

}}

Fenelzine-tranylcypromine

2026-04-14T14:28:13Z

Joost:

{{Drugswitch
| from = fenelzine
| to = tranylcypromine
| stop =
{{14dWashout}}<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>

| start =
{{Starttranyl}}
| caveat =
{{caveSS}}
{{switchMAO}}

}}

Fenelzine-tranylcypromine

2026-04-14T14:26:38Z

Joost: Created page with "{{Drugswitch | from = fenelzine | to = tranylcypromine | stop = {{14dWashout}}<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranyl..."

Template:SwitchMAO

2026-04-14T14:25:10Z

Joost:

*Tranylcypromine and fenelzine are irreversible MAO inhibitors for MAO-A and MAO-B. Fenelzine has higher affinity for MAO-A, whereas tranylcypromine has higher affinity for MAO-B. Side effects could occur during a switch. In addition, monitoring of sodium levels is adviced.<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021</ref>
*Known side effect for tranylcypromine are sleeping problems, agitation and orthostatic hypotension.
*Known side effects in fenelzine are oedema and/or increased liver enzyme levels.
* It is adviced to admit the patient in a mental health care clinic for intensive monitoring during this switch.<ref>van den Eynde et al. Richtlijn voor het gebruik van klassieke MAO-remmers Psyfar 2023 nr 2</ref>

Template:SwitchMAO

2026-04-14T14:24:58Z

Joost:

Template:SwitchMAO

2026-04-14T14:24:08Z

Joost:

*Tranylcypromine and fenelzine are irreversible MAO inhibitors for MAO-A and MAO-B. Fenelzine has higher affinity for MAO-A, whereas tranylcypromine has higher affinity for MAO-B. Side effects could occur during a switch. In addition, monitoring of sodium levels is adviced.<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021</ref>
*Known side effect for tranylcypromine are sleeping problems, agitation and orthostatic hypotension.
*Known side effects in fenelzine are oedema and/or increased liver enzyme levels.
* It is adviced to admit the patient in a mental health care clinic for intensive monitoring during this switch.<ref>Richtlijn voor het gebruik van klassieke MAO-remmers
van den Eynde Psyfar 2023 nr2</ref>

Template:SwitchMAO

2026-04-14T14:22:20Z

Joost:

*Tranylcypromine and fenelzine are irreversible MAO inhibitors for MAO-A and MAO-B. Fenelzine has higher affinity for MAO-A, whereas tranylcypromine has higher affinity for MAO-B. Side effects could occur during a switch. In addition, monitoring of sodium levels is adviced.<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021</ref>
*Known side effect for tranylcypromine are sleeping problems, agitation and orthostatic hypotension.
*Known side effects in fenelzine are oedema and/or increased liver enzyme levels.
* It is adviced to admit the patient in a mental health care clinic for intensive monitoring during this switch.<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>

Template:SwitchMAO

2026-04-14T14:21:25Z

Joost:

Template:SwitchMAO

2026-04-14T14:19:51Z

Joost:

Template:SwitchMAO

2026-04-14T14:19:07Z

Joost:

*Tranylcypromine and fenelzine are irreversible MAO inhibitors for MAO-A and MAO-B. Fenelzine has higher affinity for MAO-A, whereas tranylcypromine has higher affinity for MAO-B. Side effects could occur during a switch. Known side effect for tranylcypromine are sleeping problems, agitation and orthostatic hypotension. Known side effects in fenelzine are oedema and/or increased liver enzyme levels. In addition, monitoring of sodium levels is adviced.<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021</ref>

Template:SwitchMAO

2026-04-14T14:12:27Z

Joost:

*<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021</ref>

Template:SwitchMAO

2026-04-14T14:11:49Z

Joost: Created page with "*<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021<ref>"

*<ref>A van Diepen et al. De lange mars van farma naar patiënt Medisch Contact May 2021<ref>

Tranylcypromine-fenelzine

2026-04-14T14:08:48Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
{{switchMAO}}

}}

Tranylcypromine-fenelzine

2026-04-14T14:08:37Z

Joost:

Tranylcypromine-fenelzine

2026-04-14T14:08:15Z

Joost:

Tranylcypromine-fenelzine

2026-04-14T14:08:04Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
* Test
<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>
}}

Tranylcypromine-fenelzine

2026-04-14T14:07:45Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>
}}

Tranylcypromine-fenelzine

2026-04-14T14:06:47Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}
<ref>van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.</ref>

Tranylcypromine-fenelzine

2026-04-14T14:06:28Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}
<ref>"van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.
"</ref>

Tranylcypromine-fenelzine

2026-04-14T14:06:16Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}
<ref name=>"van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.
"</ref>

Tranylcypromine-fenelzine

2026-04-14T14:04:31Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}
<ref name="van den Eynde et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.
"</ref>

Tranylcypromine-fenelzine

2026-04-14T14:03:07Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}
<ref name="informatorium">{{KNMP|tranylcypromine}}</ref>

CNS Spectr 2023;28(4):427-440. doi: 10.1017/S1092852922000906.

Citalopram-fenelzine

2026-04-14T14:00:32Z

Joost:

{{Drugswitch
| from = citalopram
| to = fenelzine
| stop =
{{generaldecrease25p3d}}
{{7dWashout}}

| start =
*a wash-out period of 7 days is necessary.
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Tranylcypromine-fenelzine

2026-04-14T14:00:00Z

Joost:

Tranylcypromine-fenelzine

2026-04-14T13:58:29Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.
{{14dWashout}}

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Template:14dWashout

2026-04-14T13:57:31Z

Joost:

*Stop and wait 14 days for washout

Tranylcypromine-fenelzine

2026-04-14T13:56:27Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks. A washout

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Trazodone-fenelzine

2026-04-14T13:52:39Z

Joost:

{{ Drugswitch
| from = trazodone
| to = fenelzine
| stop =
{{stopTrazodone}}
| start =
* Only a washout of 3 days (so start at Day 4) is necessarily when the dose of trazodone is >50 mg. When the dose of trazodone is =< 50mg, fenelzine can be started immediately
{{startfenel}}
| info =
* {{theorSS}}
}}

Trazodone-tranylcypromine

2026-04-14T13:52:08Z

Joost:

{{ Drugswitch
| from = trazodone
| to = tranylcypromine
| stop =
{{stopTrazodone}}
| start =
* Only a washout of 3 days (so start at Day 4) is necessarily when the dose of trazodone is >50 mg. When the dose of trazodone is =< 50mg, tranylcypromine can be started immediately
{{starttranyl}}
| info =
* {{theorSS}}
}}

Tranylcypromine-fenelzine

2026-04-14T13:45:51Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks. Until a dose of 20 mg/day

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Tranylcypromine-fenelzine

2026-04-14T13:38:52Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
*Decrease tranylcypromine with 10 mg every 2 weeks.

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Tranylcypromine-fenelzine

2026-04-14T13:38:18Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
decrease tranylcypromine with 10 mg every 2 weeks.

| start =
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Tranylcypromine-fenelzine

2026-04-14T13:38:03Z

Joost:

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
decrease tranylcypromine with 10 mg every 2 weeks.
{{7dWashout}}

| start =
*a wash-out period of 7 days is necessary.
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Tranylcypromine-fenelzine

2026-04-14T13:32:55Z

Joost: Created page with "{{Drugswitch | from = tranylcypromine | to = fenelzine | stop = {{generaldecrease25p3d}} {{7dWashout}} | start = *a wash-out period of 7 days is necessary. {{Startfenel}} |..."

{{Drugswitch
| from = tranylcypromine
| to = fenelzine
| stop =
{{generaldecrease25p3d}}
{{7dWashout}}

| start =
*a wash-out period of 7 days is necessary.
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Fenelzine

2026-04-14T13:32:09Z

Joost: Created page with "{{Drug | name = Fenelzine | group = MAO-I | ftk = fenelzine | type = Antidepressant | <includeonly> isswitch=1</includeonly> }}"

{{Drug
| name = Fenelzine
| group = MAO-I
| ftk = fenelzine
| type = Antidepressant
| <includeonly> isswitch=1</includeonly>
}}

Start-fenelzine

2026-04-14T13:29:23Z

Joost: Created page with "{{drugswitch | to = fenelzine | start = {{StartAntidepressive}} }}"

{{drugswitch
| to = fenelzine
| start = {{StartAntidepressive}}
}}

Vortioxetine-fenelzine

2026-04-14T13:28:48Z

Joost:

{{Drugswitch
| from = vortioxetine
| to = fenelzine
| stop =
* '''Day 1:''' Stop vortioxetine.
* vortioxetine can be stopped abruptly for every dosage.<ref>Multidisciplinair document Afbouwen Overige Antidepressiva 2023</ref>
{{14dwashout}}
| start =
* a wash-out period of two weeks is necessary.
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Vortioxetine-fenelzine

2026-04-14T13:28:39Z

Joost: Created page with "{{Drugswitch | from = vortioxetine | to = fenelzine | stop = * '''Day 1:''' Stop vortioxetine. * vortioxetine can be stopped abruptly for every dosage.<ref>Multidisciplinai..."

Venlafaxine-fenelzine

2026-04-14T13:28:07Z

Joost: Created page with "{{Drugswitch | from = venlafaxine | to = fenelzine | stop = {{stopVenlafaxine}} * Stop and wait 5 days for washout | start = *a wash-out period of 5 days is necessary. {{s..."

{{Drugswitch
| from = venlafaxine
| to = fenelzine
| stop =
{{stopVenlafaxine}}
* Stop and wait 5 days for washout
| start =
*a wash-out period of 5 days is necessary.
{{startfenel}}
| caveat =
{{caveSS}}

}}

Trazodone-fenelzine

2026-04-14T13:26:44Z

Joost: Created page with "{{ Drugswitch | from = trazodone | to = fenelzine | stop = {{stopTrazodone}} | start = * Only a washout of 3 days (so start at Day 4) is necessarily when the dose of trazo..."

{{ Drugswitch
| from = trazodone
| to = fenelzine
| stop =
{{stopTrazodone}}
| start =
* Only a washout of 3 days (so start at Day 4) is necessarily when the dose of trazodone is >100 mg. When the dose of trazodone is =< 100mg, tranylcypromine can be started immediately
{{startfenel}}
| info =
* {{theorSS}}
}}

Sertraline-fenelzine

2026-04-14T13:21:16Z

Joost: Created page with "{{Drugswitch | from = sertraline | to = fenelzine | stop = {{generaldecrease25p3d}} {{7dWashout}} | start = *a wash-out period of 7 days is necessary. {{Startfenel}} | cav..."

{{Drugswitch
| from = sertraline
| to = fenelzine
| stop =
{{generaldecrease25p3d}}
{{7dWashout}}

| start =
*a wash-out period of 7 days is necessary.
{{Startfenel}}
| caveat =
{{caveSS}}
}}

Paroxetine-fenelzine

2026-04-14T13:20:44Z

Joost: Created page with "{{Drugswitch | from = paroxetine | to = fenelzine | stop = {{generaldecrease25p3d}} {{7dWashout}} | start = *a wash-out period of 7 days is necessary. {{Startfenel}} | ca..."

{{Drugswitch
| from = paroxetine
| to = fenelzine
| stop =
{{generaldecrease25p3d}}
{{7dWashout}}

| start =
*a wash-out period of 7 days is necessary.
{{Startfenel}}
| caveat =
{{caveSS}}
}}